Omblastys
Country: European Union
Language: Slovenian
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
14-06-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
iodine (131I) omburtamab
Available from:
Y-Mabs Therapeutics A/S
ATC code:
V10XA
INN (International Name):
iodine (131I) omburtamab
Therapeutic group:
Terapevtski radiofarmacevtiki
Therapeutic area:
Neuroblastom
Therapeutic indications:
Treatment of neuroblastoma.
Authorization status:
Zavrnil
